Le Lézard
Classified in: Oil industry, Business
Subjects: ERP, ACC

Advance Notice Royal Dutch Shell Plc Third Quarter 2017 Results


THE HAGUE, Netherlands, October 10, 2017 /PRNewswire/ --

On Thursday, November 2nd, 2017 at 07.00 GMT (08.00 CET and 03.00 EDT) Royal Dutch Shell plc (NYSE: RDS.A)(NYSE: RDS.B) will release its third quarter results and third quarter interim dividend announcement for 2017.  

These announcements will be available on http://www.shell.com/investor

For enquiries please contact:
Shell Media Relations: +44(0)20-793-455-50    
Shell Investor Relations: +31(0)70-377-4540/+1-832-337-2034

SOURCE Royal Dutch Shell plc


These press releases may also interest you

at 16:05
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the full year ended December 31, 2023, and provided an overview of recent developments....

at 16:05
Danimer Scientific, Inc. ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended...

at 16:05
EACO Corporation today reported the results for its quarter ended February 29, 2024. Net sales, net income and earnings per share were as follows for the three months ended February 29, 2024 (dollars in thousands, except per share information):...

at 16:05
CVD Equipment Corporation , today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. Manny Lakios, President and CEO of CVD Equipment Corporation, commented, "Fourth quarter 2023 revenue was $4.1...

at 16:05
Leafly Holdings, Inc. ("Leafly" or "the Company") , a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced financial results for its fourth quarter and year ended December 31, 2023. "We saw continued...

at 16:05
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter and full year ended December...



News published on and distributed by: